WAYSTAR HOLDING CORP (WAY) Stock Fundamental Analysis
NASDAQ:WAY - US9467841055 - Common Stock
36.17 USD
+0.42 (+1.17%)
Taking everything into account, WAY scores 6 out of 10 in our fundamental rating. WAY was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and the financial health of WAY get a neutral evaluation. Nothing too spectacular is happening here. WAY is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year WAY was profitable.
In the past year WAY had a positive cash flow from operations.
1.2 Ratios
The Return On Assets of WAY (1.84%) is better than 88.57% of its industry peers.
WAY's Return On Equity of 2.71% is amongst the best of the industry. WAY outperforms 88.57% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.67%, WAY is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for WAY is significantly below the industry average of 7.09%.
The 3 year average ROIC (2.09%) for WAY is below the current ROIC(3.67%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 2.71% | ||
| ROIC | 3.67% |
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 8.50%, WAY belongs to the top of the industry, outperforming 94.29% of the companies in the same industry.
WAY has a Operating Margin of 20.80%. This is amongst the best in the industry. WAY outperforms 94.29% of its industry peers.
In the last couple of years the Operating Margin of WAY has grown nicely.
WAY has a Gross Margin of 67.32%. This is in the better half of the industry: WAY outperforms 68.57% of its industry peers.
In the last couple of years the Gross Margin of WAY has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.8% | ||
| PM (TTM) | 8.5% | ||
| GM | 67.32% |
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
2. Health
2.1 Basic Checks
WAY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for WAY has been increased compared to 1 year ago.
Compared to 1 year ago, WAY has an improved debt to assets ratio.
2.2 Solvency
WAY has an Altman-Z score of 2.90. This is not the best score and indicates that WAY is in the grey zone with still only limited risk for bankruptcy at the moment.
WAY has a better Altman-Z score (2.90) than 68.57% of its industry peers.
WAY has a debt to FCF ratio of 4.45. This is a neutral value as WAY would need 4.45 years to pay back of all of its debts.
WAY has a Debt to FCF ratio of 4.45. This is in the better half of the industry: WAY outperforms 62.86% of its industry peers.
WAY has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
WAY has a worse Debt to Equity ratio (0.39) than 65.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.45 | ||
| Altman-Z | 2.9 |
ROIC/WACC0.37
WACC9.85%
2.3 Liquidity
WAY has a Current Ratio of 3.43. This indicates that WAY is financially healthy and has no problem in meeting its short term obligations.
WAY's Current ratio of 3.43 is fine compared to the rest of the industry. WAY outperforms 80.00% of its industry peers.
WAY has a Quick Ratio of 3.43. This indicates that WAY is financially healthy and has no problem in meeting its short term obligations.
WAY has a Quick ratio of 3.43. This is in the better half of the industry: WAY outperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.43 | ||
| Quick Ratio | 3.43 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 199.63% over the past year.
Looking at the last year, WAY shows a quite strong growth in Revenue. The Revenue has grown by 17.14% in the last year.
The Revenue has been growing by 17.71% on average over the past years. This is quite good.
EPS 1Y (TTM)199.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
Revenue 1Y (TTM)17.14%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%15.4%
3.2 Future
Based on estimates for the next years, WAY will show a very strong growth in Earnings Per Share. The EPS will grow by 76.92% on average per year.
WAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.10% yearly.
EPS Next Y323.93%
EPS Next 2Y118.74%
EPS Next 3Y76.92%
EPS Next 5YN/A
Revenue Next Year9.88%
Revenue Next 2Y9.63%
Revenue Next 3Y10.1%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
WAY is valuated quite expensively with a Price/Earnings ratio of 32.59.
Based on the Price/Earnings ratio, WAY is valued a bit cheaper than 80.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of WAY to the average of the S&P500 Index (26.76), we can say WAY is valued slightly more expensively.
Based on the Price/Forward Earnings ratio of 23.84, the valuation of WAY can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of WAY indicates a somewhat cheap valuation: WAY is cheaper than 74.29% of the companies listed in the same industry.
WAY's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.91.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.59 | ||
| Fwd PE | 23.84 |
4.2 Price Multiples
WAY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. WAY is cheaper than 74.29% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of WAY indicates a somewhat cheap valuation: WAY is cheaper than 80.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.62 | ||
| EV/EBITDA | 18.86 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
WAY has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as WAY's earnings are expected to grow with 76.92% in the coming years.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y118.74%
EPS Next 3Y76.92%
5. Dividend
5.1 Amount
No dividends for WAY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:WAY (8/22/2025, 1:30:07 PM)
36.17
+0.42 (+1.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners66.37%
Inst Owner Change5.58%
Ins Owners1.29%
Ins Owner Change5.81%
Market Cap6.30B
Analysts85.56
Price Target51.26 (41.72%)
Short Float %3.63%
Short Ratio2.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.52%
Min EPS beat(2)-1.27%
Max EPS beat(2)6.31%
EPS beat(4)3
Avg EPS beat(4)34.74%
Min EPS beat(4)-1.27%
Max EPS beat(4)103.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.16%
Min Revenue beat(2)2.36%
Max Revenue beat(2)3.95%
Revenue beat(4)4
Avg Revenue beat(4)4.17%
Min Revenue beat(4)2.36%
Max Revenue beat(4)6.23%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.61%
PT rev (3m)5.13%
EPS NQ rev (1m)4.04%
EPS NQ rev (3m)4.67%
EPS NY rev (1m)0%
EPS NY rev (3m)0.79%
Revenue NQ rev (1m)0.82%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0.49%
Revenue NY rev (3m)0.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.59 | ||
| Fwd PE | 23.84 | ||
| P/S | 6.23 | ||
| P/FCF | 22.62 | ||
| P/OCF | 20.69 | ||
| P/B | 1.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.86 |
EPS(TTM)1.11
EY3.07%
EPS(NY)1.52
Fwd EY4.2%
FCF(TTM)1.6
FCFY4.42%
OCF(TTM)1.75
OCFY4.83%
SpS5.8
BVpS18.21
TBVpS-4.76
PEG (NY)0.1
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 2.71% | ||
| ROCE | 4.65% | ||
| ROIC | 3.67% | ||
| ROICexc | 3.97% | ||
| ROICexgc | 91.57% | ||
| OM | 20.8% | ||
| PM (TTM) | 8.5% | ||
| GM | 67.32% | ||
| FCFM | 27.55% |
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
ROICexc(3y)2.13%
ROICexc(5y)N/A
ROICexgc(3y)47.51%
ROICexgc(5y)N/A
ROCE(3y)2.64%
ROCE(5y)N/A
ROICexcg growth 3Y7.56%
ROICexcg growth 5YN/A
ROICexc growth 3Y30.65%
ROICexc growth 5YN/A
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
F-Score8
Asset Turnover0.22
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.45 | ||
| Debt/EBITDA | 3.27 | ||
| Cap/Depr | 15.78% | ||
| Cap/Sales | 2.57% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.15% | ||
| Profit Quality | 324.12% | ||
| Current Ratio | 3.43 | ||
| Quick Ratio | 3.43 | ||
| Altman-Z | 2.9 |
F-Score8
WACC9.85%
ROIC/WACC0.37
Cap/Depr(3y)12.11%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)199.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
EPS Next Y323.93%
EPS Next 2Y118.74%
EPS Next 3Y76.92%
EPS Next 5YN/A
Revenue 1Y (TTM)17.14%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%15.4%
Revenue Next Year9.88%
Revenue Next 2Y9.63%
Revenue Next 3Y10.1%
Revenue Next 5YN/A
EBIT growth 1Y85.59%
EBIT growth 3Y27.06%
EBIT growth 5YN/A
EBIT Next Year134.34%
EBIT Next 3Y42.19%
EBIT Next 5YN/A
FCF growth 1Y375.9%
FCF growth 3Y15.76%
FCF growth 5YN/A
OCF growth 1Y229.9%
OCF growth 3Y16.85%
OCF growth 5YN/A